RETRACTED: Comparative pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 and propofol emulsion (Retracted article. See vol. 112, pg. 1058, 2010)

被引:49
作者
Fechner, J
Ihmsen, H
Hatterscheid, D
Jeleazcov, C
Schiessl, C
Vornov, JJ
Schwilden, H
Schüttler, J
机构
[1] Univ Erlangen Nurnberg, Anasthesiol Klin, D-91054 Erlangen, Germany
[2] Guildford Pharmaceut, Baltimore, MD USA
关键词
D O I
10.1097/00000542-200409000-00011
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: GPI 15715 is a new water-soluble prodrug that is hydrolyzed to release propofol. The objectives of this crossover study in volunteers were to investigate the pharmacokinetics and pharmacodynamics of GPI 15715 in comparison with propofol emulsion. Methods: In two separate sessions, nine healthy male volunteers (19-35 yr, 70-86 kg) received GPI 15715 and propofol emulsion as a target controlled infusion over 60 min. In the first 20 min, the propofol target concentration increased linearly to 5 mug/ml. Subsequently, the targets were reduced to 3 mug/ml and 1.5 mug/ml for 20 min each. The plasma concentrations of GPI 15715 and propofol were measured from arterial and venous blood samples up to 24 h and pharmacokinetics were analyzed. The pharmacodynamic effect was measured by the median frequency of the power spectrum of the electroencephalogram, and a sigmoid model with effect compartment was fitted to the data. Results: Compared with propofol emulsion, propofol from GPI 15715 showed a different disposition function and especially larger volumes of distribution. The propofol effect site concentration for half maximum effect was 2.0 +/- 0.5 mug/ml for GPI 15715 and 3.0 +/- 0.7 mug/ml for propofol emulsion (P < 0.05). Propofol from GPI 15715 did not show a hysteresis between plasma concentration and effect. Conclusions: Compared with propofol emulsion, propofol from GPI 15715 showed different pharmacokinetics and pharmacodynamics, particularly a higher potency with respect to concentration. These differences may indicate an influence of the formulation.
引用
收藏
页码:626 / 639
页数:14
相关论文
共 28 条
[1]  
Albrecht S, 1999, ANAESTHESIST, V48, P794, DOI 10.1007/s001010050787
[2]   A comparison of spectral edge, delta power, and bispectral index as EEG measures of alfentanil, propofol, and midazolam drug effect [J].
Billard, V ;
Gambus, PL ;
Chamoun, N ;
Stanski, DR ;
Shafer, SL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (01) :45-58
[3]  
CHERNIK DA, 1990, J CLIN PSYCHOPHARM, V10, P244
[4]   Pharmacokinetic-pharmacodynamic modelling of the EEG effects of Ro 48-6791, a new short-acting benzodiazepine, in young and elderly subjects [J].
Dingemanse, J ;
Haussler, J ;
Hering, W ;
Ihmsen, H ;
Albrecht, S ;
Zell, M ;
Schwilden, H ;
Schuttler, J .
BRITISH JOURNAL OF ANAESTHESIA, 1997, 79 (05) :567-574
[5]   Role of propofol and its solvent, intralipid, in nitric oxide-induced peripheral vasodilatation in dogs [J].
Doursout, MF ;
Joseph, PM ;
Liang, YY ;
Hartley, CJ ;
Chelly, JE .
BRITISH JOURNAL OF ANAESTHESIA, 2002, 89 (03) :492-498
[6]   Formulation-dependent pharmacokinetics and pharmacodynamics of propofol in rats [J].
Dutta, S ;
Ebling, WF .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1998, 50 (01) :37-42
[7]   Formulation-dependent brain and lung distribution kinetics of propofol in rats [J].
Dutta, S ;
Ebling, WF .
ANESTHESIOLOGY, 1998, 89 (03) :678-685
[8]   The pharmacokinetics and pharmacodynamics of propofol in a modified cyclodextrin formulation (Captisol®) versus propofol in a lipid formulation (Diprivano®):: An electroencephalographic and hemodynamic study in a porcine model [J].
Egan, TD ;
Kern, SE ;
Johnson, KB ;
Pace, NL .
ANESTHESIA AND ANALGESIA, 2003, 97 (01) :72-79
[9]   RETRACTED: Pharmacokinetics and clinical pharmacodynamics of the new propofol prodrug GPI 15715 in volunteers (Retracted article. See vol. 112, pg. 1058, 2010) [J].
Fechner, J ;
Ihmsen, H ;
Hatterscheid, D ;
Schiessl, C ;
Vornov, JJ ;
Burak, E ;
Schwilden, H ;
Schüttler, JR .
ANESTHESIOLOGY, 2003, 99 (02) :303-313
[10]   PROPOFOL INFUSION AND THE SUPPRESSION OF CONSCIOUSNESS - THE EEG AND DOSE REQUIREMENTS [J].
FORREST, FC ;
TOOLEY, MA ;
SAUNDERS, PR ;
PRYSROBERTS, C .
BRITISH JOURNAL OF ANAESTHESIA, 1994, 72 (01) :35-41